Thanks Joe Cool for this 2022 Conference Call link.
It was the most positive conference call ever...
No explaining ...as a great percentage increase in revenue...
Tony sounded so excited and up beat and he said had early today AM meeting with FDA re Resapp dx and it's promising approval for Adults and children....
We did not run adult study in US...
So this was huge information..
So have a listen to the cream of Resapphealth Conference calls..
Well done RAP team...
All my optimistic opinion
MB
RAP Price at posting:
5.9¢ Sentiment: Buy Disclosure: Held